How many times have you heard that “the important thing is to participate”? Whoever said it surely did not think that a judgment of the Court of Justice of the European Union (CJEU) would ever uphold their thesis. Or, at the very least, that it would point out that Member States cannot  exclude at first... Read More

In recent years, payment-by-results models have proliferated for the incorporation of therapeutic innovations into public funding. The same is true for the acquisition of these innovations by regional health systems and/or hospitals. Although there is a certain consensus on the advantages of these models, especially in a context of therapeutic advances with very high expectations... Read More